Drug intelligence / Profile preview

zhongyao anshen prescription

Development stage: Preclinical
Lead developer: Hubei Provincial Traditional Chinese Medical Hospital
Administration: Oral

Overview

Zhongyao anshen prescription is a Traditional Chinese Medicine (TCM) formulation being investigated for the prevention and treatment of insomnia. It is based on the 'three causes and measures theory', a concept within TCM. The prescription is currently in development, with research being conducted by institutions such as Hubei Provincial Hospital of Traditional Chinese Medicine, the Ministry of Science & Technique, China, and Hubei University of Chinese Medicine.

Other names: 中药安神方

Beyond the preview

Go deeper on zhongyao anshen prescription.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhongyao anshen prescription.

Explore the full profile